,for, Item ID-
  • #564814
  • Novo Nordisk Pharmaceutical #00169368512

NovoLog® Mix 70/30 Insulin Aspart Protamine / Insulin Aspart 70 U - 30 U / mL Injection 10 mL

NOVOLOG, VL 70/30U/ML 10ML

Features

  • NovoLog Mix 70/30 is indicated for the treatment of patients with diabetes mellitus for the control of hyperglycemia
  • NovoLog Mix 70/30 is a blood glucose lowering agent with a rapid onset and an intermediate duration of action
  • NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]) is a human insulin analog suspension containing 70% insulin aspart protamine crystals and 30% soluble insulin aspart
  • More …
  Log In to Order
or

Product Specifications


Features
  • NovoLog Mix 70/30 is indicated for the treatment of patients with diabetes mellitus for the control of hyperglycemia
  • NovoLog Mix 70/30 is a blood glucose lowering agent with a rapid onset and an intermediate duration of action
  • NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]) is a human insulin analog suspension containing 70% insulin aspart protamine crystals and 30% soluble insulin aspart
  • Presentation contains 100 Units of insulin aspart per mL (U-100)
More Information

Frequently Viewed Together